For most women, the clearest current answer is this: start mammography at 40 and get screened every two years through age 74. That is the final recommendation of the US Preventive Services Task Force (USPSTF) issued in 2024. The American Cancer Society (ACS), in its 2015 guideline, still offers a slightly different path — optional annual screening from 40, annual from 45, and every two years from 55 — and the honest summary is that both organizations agree screening reduces breast cancer deaths; where they differ is on the start age and the interval.
This article explains what the major guidelines recommend, why they differ, and what the trade-offs look like at each age. It publishes information, not medical advice — screening decisions belong to you and your clinician, especially if you have a family history of breast cancer or other risk factors.
What exactly does the USPSTF recommend?
The USPSTF, an independent panel of prevention experts, issued its final recommendation in April 2024: women ages 40 to 74 should be screened for breast cancer with mammography every two years (a grade B recommendation). The panel estimated, using modeling, that biennial screening from 40 to 74 averts roughly 5 breast cancer deaths per 1,000 women screened. The Task Force did not find enough evidence to make a recommendation for women 75 and older, leaving that decision to individual discussion with a clinician.
What does the American Cancer Society recommend?
The ACS guideline, last updated in 2015, layers the advice by age. Women 40 to 44 may choose to begin annual mammography. Women 45 to 54 should get a mammogram every year. From 55 on, the ACS recommends screening every two years, or continuing annually if a woman prefers, and continuing as long as she is in good health with a life expectancy of at least 10 years. Early screening can stop at any time when health status makes the benefit small.
Why do the guidelines differ?
The disagreement is really about trade-offs in a woman's 40s. Starting at 40 catches cancers earlier and saves more lives — but it also means more mammograms overall, more false-positive results that require extra imaging or biopsy, and more cases of overdiagnosis, a term for cancers detected and treated that would never have caused symptoms in a lifetime. The USPSTF weighed those harms and landed on a two-year interval starting at 40; the ACS, prioritizing earlier detection, prefers annual screening from mid-40s with an option to start at 40. Neither position is a fringe view, and the American College of Radiology goes further still, urging annual screening from 40. If you read that the 'rules changed,' what actually changed is the balance each body strikes between benefit and harm.
| Organization (year) | When to start | How often | When to stop |
|---|---|---|---|
| USPSTF (2024) | Age 40 | Every 2 years | Recommendation covers ages 40–74; individual decision after that |
| American Cancer Society (2015) | Optional at 40; recommended at 45 | Annual to 54; every 1–2 years from 55 | Continue while in good health with 10+ year life expectancy |
How common is breast cancer, really?
Breast cancer is the most common cancer diagnosed in US women apart from skin cancer. Per the National Cancer Institute's SEER program, about 1 in 8 women — roughly 13 percent — will be diagnosed with breast cancer at some point during her life, and risk rises with age: most cases are diagnosed after 50. That lifetime figure is worth holding onto when you read screening advice, because it is the population risk the guidelines are calibrated to, not a prediction about any one person.
What happens during a screening mammogram?
Mammography is a low-dose X-ray image of the breast. A technologist positions each breast between two plates and compresses it for a few seconds per view, which spreads the tissue so small changes are easier to see. The appointment itself typically takes about 20 minutes. Screening means you have no symptoms; if you or your clinician has found a lump, skin change, or nipple discharge, that is a diagnostic workup, which follows a different path and does not wait for a scheduled screening visit.
What does a result mean?
Most screening mammograms come back normal, and most abnormal findings turn out not to be cancer. A result of 'callback' or 'recall' means the radiologist wants additional views or an ultrasound to look more closely at an area — per USPSTF evidence review data, roughly 1 in 10 women screened will be called back, and only a small fraction of callbacks lead to a cancer diagnosis. Dense breast tissue, which is common, makes both callbacks and missed cancers more likely, a limitation worth knowing in advance.
Related stories: Colorectal Cancer Screening Now Starts at 45: Your Options, Compared · STI Screening: What the Guidelines Actually Recommend for Women, and When.
Why does breast density keep coming up?
Dense breasts have proportionally more glandular and connective tissue than fatty tissue, and on a mammogram both dense tissue and tumors appear white, which can hide a cancer. As of September 2024, an FDA rule requires all US mammography facilities to tell women their breast density category in the results letter. Dense tissue is common — roughly half of women over 40 have it — and is itself a modest independent risk factor. What remains unsettled is whether women with dense breasts should add ultrasound or MRI to mammography; the evidence on whether supplemental screening reduces deaths is not strong enough for a blanket recommendation, so this is a specific conversation to have with a clinician.
What if breast cancer runs in your family?
Guideline age tables apply to women at average risk. A first-degree relative (mother, sister, daughter) with breast cancer, a known BRCA1 or BRCA2 mutation in the family, or prior chest radiation all shift the calculation toward earlier and more frequent screening, sometimes with MRI added to mammography. Per the USPSTF's 2019 recommendation, women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer should be offered genetic counseling to assess whether testing makes sense. If this describes you, the age-by-age tables are a starting point for the conversation, not the plan itself.
How do you weigh the benefits and the harms?
A calm way to frame it: for every 1,000 women screened biennially from 40 to 74, USPSTF modeling estimates about 5 breast cancer deaths averted. Against that, the same reviews count false positives, unnecessary biopsies, and overdiagnosis — real harms, though their weight is a matter of values as much as statistics. Some women will accept frequent callbacks as the cost of earlier detection; others will find the anxiety of each callback outweighs a small mortality benefit. Both responses are reasonable, which is precisely why two respected panels can read the same evidence and issue different schedules.
When to talk to a clinician
Talk with a clinician about a personalized plan if you are 40 or older and have not scheduled a first mammogram; if you have a family history of breast or ovarian cancer; if you received a breast density notification and are wondering about supplemental imaging; if you are 75 or older and deciding whether to continue; or at any age if you notice a new lump, skin dimpling, nipple discharge, or a change in breast shape. Symptomatic breasts are not a screening question — they deserve prompt evaluation, not a wait for the next scheduled mammogram.
Frequently asked questions
Is 3D mammography (tomosynthesis) better than a standard 2D mammogram?
Digital breast tomosynthesis takes images in thin slices, which reduces callback rates and finds slightly more cancers, per studies reviewed by the USPSTF in 2024. Whether it reduces breast cancer deaths compared with 2D mammography has not been proven. Most US facilities now offer it, and it is a reasonable option to accept if available, but the larger choice — starting age and interval — matters more.
Do I need a referral or a doctor's order for a screening mammogram?
In most US states a self-referral is allowed: you can schedule a screening mammogram directly at an accredited facility once you meet guideline age criteria. Coverage details vary by insurance plan, though under the Affordable Care Act, services graded A or B by the USPSTF — which includes biennial mammography for women 40 to 74 — are generally covered without cost-sharing.
What if I missed a few years?
Simply resume. There is no penalty for a gap and no catch-up protocol; the recommendation is the same biennial or annual schedule as before, depending on which guideline you and your clinician follow. If a specific change in your breasts prompted the pause, mention it at the appointment so it is evaluated as a diagnostic concern, not folded into routine screening.
Does an ultrasound or self-exam replace a mammogram?
No. Ultrasound is a supplemental tool, mainly for dense breasts or evaluating a specific finding, and there is no evidence that breast self-examination alone reduces breast cancer deaths, per the USPSTF's reviews. Many clinicians now encourage 'breast awareness' — knowing how your breasts normally look and reporting changes — rather than a formal monthly self-exam routine.